Table 2.
Table 2. Modulation of autophagy by antipsychotics in non-neuronal cells.
"Flux" refers to autophagic flux; ↑ denotes increase/activation; ↓ denotes decrease/inhibition; n.a. - not assessed; ATZ - α1-antitrypsin Z; ER - endoplasmic reticulum; PKC - protein kinase C.
| Agent | Cells/Tissues | LC3-II | Flux | Mechanisms | Effects | Ref. |
| Thioridazine | GBM8401, U87MG glioma cells | ↑ | ↑ | AMPK↑ | Apoptotic death; Tumor growth in vivo↓ | 53 |
| Trifluoperazine | MDA-MB-231 breast cancer cells | ↑ | n.a. | n.a. | Migration↓; Invasiveness↓ | 54 |
| Trifluoperazine | Ca922, SCC2095, primary oral cancer cells | ↑ | n.a. | Akt/mTORC1↓ | Apoptotic death; Tumor growth in vivo↓ | 58 |
| Trifluoperazine | HeLa cells | ↑ | ↑ | n.a. | Bacterial clearance | 61 |
| Trifluoperazine | H4 glioma cells | ↑ | ↑ | Ca2+↓, calpain↓, ATG5 cleavage↓ | Clearance of mutant; poliglutamine | 13,59 |
| Fluspirilene | H4 glioma cells | ↑ | ↑ | Ca2+↓, calpain↓, ATG5 cleavage↓ | Clearance of mutant; poliglutamine | 13,59 |
| Pimozide | H4 glioma cells | ↑ | ↑ | Ca2+↓, calpain↓, ATG5 cleavage↓ | Clearance of mutant; poliglutamine | 13,59 |
| Penfluridol | Panc-1, AsPC-1, BxPC-3; pancreatic cancer cells | ↑ | ↑ | n.a. | Apoptotic death; Tumor growth in vivo↓ | 55 |
| Chlorpromazine | U87MG glioma cells | ↑ | ↑ | Akt/mTORC1↓ | Apoptotic death; Tumor growth in vivo↓ | 56 |
| Olanzapine | LN229, T98 glioma cells | ↑ | ↑ | n.a. | Apoptotic death; Tumor growth in vivo↓ | 57 |
| Clozapine | A549, H1299 lung cancer cells | ↑ | ↑ | n.a. | Cell cycle arrest; Cell death | 60 |
| Clozapine | Mouse skeletal muscle | ↓ | n.a. | PKCβ↑, LC3 conversion↓ | Lipid droplet clearance↓; Weight gain | 63 |
| Fluphenazine | Mouse liver | ↑ | n.a. | n.a. | ATZ clearance; Liver fibrosis↓ | 62 |